Serine- and metallo-β-lactamases present a threat to the clinical use of nearly all β-lactam antibiotics, including penicillins, cephalosporins, and carbapenems. Efforts to develop metallo-β-lactamase (MBL) inhibitors require suitable screening platforms to allow the rapid determination of β-lactamase activity and efficient inhibition. Unfortunately, the platforms currently available are not ideal for this purpose. Further progress in MBL inhibitor identification requires inexpensive and wide...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Chromophore-linked substrate (CLS405): probing metallo-β-lactamase activity and inhibition.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record